Skip to main content
Clinical Trials/NCT06266195
NCT06266195
Recruiting
Not Applicable

Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the Infrared

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country64 target enrollmentMarch 15, 2023
ConditionsVesicle

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vesicle
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
64
Locations
1
Primary Endpoint
primary endpoint
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Extracellular vesicles, due to their ease of extraction and ability to represent the cells from which they originate, have high potential in the field of personalized medicine, especially in the identification of new early bio-markers of cancer, including hepatocellular carcinoma. Nevertheless, the development of high-throughput diagnostic methods in this area is still in its infancy, and the design of new integrated technological solutions is of great interest and topicality. The main hypothesis of this study is that the development of a novel technology integrating resonant gold nanostructures in the mid-infrared can significantly contribute to the development of new approaches for the diagnosis of hepatocellular carcinoma.

Registry
clinicaltrials.gov
Start Date
March 15, 2023
End Date
February 28, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

primary endpoint

Time Frame: 12 months

To evaluate the change in extracellular vesicle concentration between the control group and oncology group. The concentration of vesicles per ml of blood will be measured by frequency shift of the plasmonic resonance peak of gold nanostructures following immuno-capture of vesicles.

Study Sites (1)

Loading locations...

Similar Trials